Using Zero-Balance Ultrafiltration With Dialysate as a Replacement Solution for Toxin and Eptifibatide Removal on a Dialysis-Dependent Patient During Cardiopulmonary Bypass
C ARDIAC DISEASE is very prevalent in patients with end-stage renal disease (ESRD) dependent on hemodialysis (HD).1 While HD-dependent patients commonly are referred for cardiac surgery, their multiple comorbidities, including diabetes, peripheral vascular disease, anemia and cachexia, and others, make perioperative management challenging.2,3 It has been shown that perioperative management of fluid balance, electrolytes, metabolic acidosis, and azotemia plays an important role in operative morbidity and mortality in these patients.
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Michele Heath, Atilio Barbeito, Ian Welsby, Cory Maxwell, Alexander Iribane, Karthik Raghunathan Tags: Case Report Source Type: research
More News: Anemia | Anesthesia | Anesthesiology | Cardiology | Diabetes | Dialysis | Endocrinology | Eptifibatide | Heart | Hemodialysis | Integrilin | Peripheral Vascular Disease (PVD)